Form 4 for OM Outset Medical, Inc.

Accepted 2024-01-17 00:00:00 ET · period of report 2024-01-12 · accession 0001484612-24-000017 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2024-01-17	2024-01-16	OM	Porter Stacey L.	CHRO	S - Sale	$4.29	-768	61.4K	-1%	-$3,295
	2024-01-17	2024-01-12	OM	Porter Stacey L.	CHRO	A - Grant	$0.00	+3,586	62.2K	+6%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-16	S	D	768	$4.29	61,448	D	—	—	(F2) Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (1) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
2	Common	Common Stock	2024-01-12	A	A	3,586	$0.00	62,216	D	—	—	(F1) On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date.